Single-slice Functional Lung MRI During Metronome-Paced Tachypnea Detects Changes in Regional Ventilation Dynamics After a Single Dose of Dual Bronchodilator Treatment in COPD.

COPDAug 12, 2026 (epub)
Clinical ResearchPulmonology

Robin A Müller, Andreas Voskrebenzev, Filip Klimeš et al.

✦ AI-curated · Sources linked

In 30 seconds

This randomized controlled trial evaluated the effects of dual bronchodilator treatment on regional ventilation dynamics in patients with stable COPD using single-slice PREFUL MRI during metronome-paced tachypnea (MPT). The study found significant improvements in regional ventilation and flow-volume loop correlation after a single dose of treatment compared to placebo, with p-values less than 0.02.

Key findings

  • No significant improvements in MRI-derived parameters during resting tidal breathing after single-dose treatment compared to placebo.
  • During metronome-paced tachypnea, significant improvements in regional ventilation and flow-volume loop correlation were observed after single-dose treatment.
  • After multi-dose treatment, five out of six measured parameters improved during MPT compared to baseline without bronchodilator treatment.

Why it matters

Understanding the effects of dual bronchodilators on ventilation dynamics is crucial for optimizing treatment strategies in COPD. This study highlights a novel MRI approach that may enhance the assessment of treatment efficacy.

Source

PubMed · PMID 42584170

Published in COPD. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Pulmonology

Clinical ResearchHematology

Ponatinib-Blinatumomab or Imatinib-Chemotherapy for Adult Ph-Positive ALL.

This multicenter, phase 3 randomized trial compared frontline ponatinib plus blinatumomab with imatinib plus chemotherapy in adults with Philadelphia-positive acute lymphoblastic leukemia.

N Engl J MedOct 15, 2026Read summary
Clinical ResearchHematology

Efficacy and safety of mitapivat in patients with sickle cell disease (RISE UP): a phase 3, double-blind, global, randomised, placebo-controlled trial.

RISE UP was a phase 3, double-blind, global, randomised, placebo-controlled trial conducted at 69 sites in 15 countries. It evaluated twice-daily mitapivat in patients older than 16 years with sickle cell disease…

LancetOct 24, 2026Read summary
Clinical ResearchRheumatology

Ianalumab for the Treatment of Patients with Sjögren's Disease.

Two 52-week, double-blind, randomized, placebo-controlled phase III trials evaluated monthly or less frequent ianalumab in patients with active Sjögren's disease.

N Engl J MedOct 22, 2026Read summary

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text
Create my personalized digestSee plans

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.